COR vs GIPL Stock Comparison

Cencora and Global Innovative Platforms Prices as of Oct 28, 2026 Peers: Industry group
COR Cencora, Inc.
$324.43 +6.8% 1M -3.3% 1Y
Market cap
$63.27B
P/E
24.1x
Revenue (TTM)
$332.77B
Div. yield
0.01%
Drug Distribution Healthcare
5 wins

Head to Head

7 decided of 12

Cencora leads on 5 of the 12 questions below (Cencora 5, Global Innovative Platforms 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCORGIPLLeader
Larger companyMarket capitalisation $63.27B $24.88M COR
Cheaper on earningsLower P/E, profitable companies only 24.1x -36.0x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 19.0x — –
Faster revenue growthRevenue growth, trailing twelve months +5.1% — –
More profitableNet margin, trailing twelve months 0.8% -361.7% COR
Better return on capitalReturn on invested capital 14.4% — –
Less leveragedLower net debt / EBITDA 2.2x 0.4x GIPL
Higher dividend yieldTrailing dividend yield 0.01% — –
Better 1-year returnPrice return, last 12 months -3.3% -37.5% COR
Better 5-year returnAnnualised price return, 5 years +21.6%/yr -36.9%/yr COR
Less volatileAnnualised volatility, 1 year 32.7% 270.9% COR
Higher overall scoreMean of the five percentile scores vs peers 53/100 55/100 GIPL

Percentile Scorecard

CORGIPL

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCORGIPL
Valuation 63 #10 of 25 61 #244 of 625
Growth 74 #7 of 24 27 #439 of 602
Profitability 57 #11 of 24 39 #334 of 549
Financial Health 24 #20 of 26 98 #12 of 654
Shareholder Returns 47 #9 of 16 50 #184 of 367
Overall 53 55
  • COR ranked among 27 companies in Healthcare Payers and Distributors
  • GIPL ranked among 672 companies in Pharmaceuticals and Biotechnology

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCORGIPLSPY
1 month +6.8%0.0% +0.9%
3 months +1.8%0.0% +5.9%
6 months +4.2%-3.8% +8.5%
Year to date -3.9%+354.5% +13.3%
1 year -3.3%-37.5% +12.4%
3 years +72.9%-52.4% +88.1%
3 years, per year +20.0%-21.9% +23.5%
5 years +165.9%-90.0% +68.2%
5 years, per year +21.6%-36.9% +11.0%
10 years +369.2%-79.2% +263.4%
10 years, per year +16.7%-14.5% +13.8%

Risk

MeasureCORGIPLSPY
Volatility, 1Y 32.7%270.9% 12.7%
Downside volatility, 1Y 39.5%— 12.7%
Beta vs S&P 500, 1Y -0.152.26 1.00
Return / volatility, 1Y -0.10-0.14 0.98
Max drawdown, 5Y -32.6%-98.0% -25.4%
From 52-week high -13.4%-49.5% -0.9%
52-week high $374.75$0.99 $779.14
52-week low $252.74$0.11 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCORGIPL
P/E now vs peer median 23.9xmedian 23.9x -36.0xmedian 17.4x
P/S now vs peer median 0.2xmedian 0.3x 132.9xmedian 9.1x
EV/EBITDA now vs peer median 17.2xmedian 12.7x -39.5xmedian 17.1x
P/FCF now vs peer median 15.2xmedian 15.4x -32.5xmedian 19.0x
P/B now vs peer median 19.1xmedian 2.5x 46.8xmedian 2.2x
PEG now vs peer median 1.34median 1.34 -0.57median 0.34

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCORGIPL
Revenue $332.77B $187.20K
Gross profit $13.22B –
Operating income $3.04B -$677.04K
Net income $2.65B -$677.04K
Free cash flow $4.06B -$766.04K
R&D – $377.99K
EPS (diluted) $13.53 $-0.02
Cash & equivalents $2.82B $244.24K
Total debt $11.72B $8.62K
Shares (diluted) 193.94M 44.54M
Enterprise value $52.17B $24.27M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCORGIPL
P/E 23.9x -36.0x
P/FCF 15.2x -32.5x
P/Operating cash flow 12.8x -35.0x
P/S 0.2x 132.9x
P/B 19.1x 46.8x
P/Tangible book -23.0x 47.1x
EV/EBITDA 17.2x -39.5x
EV/EBIT 23.3x -36.4x
EV/Revenue 0.2x 131.6x
EV/FCF 17.4x -32.2x
EV/Operating cash flow 14.7x -34.7x
PEG (3Y EPS CAGR) 1.34 -0.57

Growth

14 metrics
MetricCORGIPL
Revenue growth (1Y) 5.1% –
Revenue CAGR (3Y) 9.4% –
Gross profit growth (1Y) 20.0% –
Gross profit CAGR (3Y) 15.0% –
Operating income growth (1Y) 11.1% -20.9%
Operating income CAGR (3Y) 9.5% -51.6%
Net income growth (1Y) 38.9% -20.9%
Net income CAGR (3Y) 16.2% -51.6%
EPS growth (1Y) 39.3% -9.8%
EPS CAGR (3Y) 17.9% 63.5%
Operating cash flow growth (1Y) 176.7% 15.8%
Operating cash flow CAGR (3Y) 14.1% -96.8%
Free cash flow growth (1Y) 255.7% 9.2%
Free cash flow CAGR (3Y) 13.3% -101.8%

Profitability

14 metrics
MetricCORGIPL
Gross margin 4.0% –
EBITDA margin 1.2% -333.4%
Operating margin 0.9% -361.7%
Pretax margin 1.1% -361.7%
Net margin 0.8% -361.7%
FCF margin 1.2% -409.2%
Operating cash flow margin 1.4% -379.8%
Return on equity 77.4% -120.8%
Return on assets 3.2% -119.7%
Return on invested capital 14.4% –
Return on capital employed 12.9% -121.4%
Asset turnover 4.0x 0.3x
Cash conversion (OCF / net income) 1.8x 1.1x
Stock comp / revenue 0.0% –

Financial Health

11 metrics
MetricCORGIPL
Debt / assets 14.0% 1.0%
Debt / equity 3.6x 0.0x
Net debt / EBITDA 2.2x 0.4x
Debt / FCF 2.9x 0.0x
Liabilities / assets 96.1% 1.4%
Equity / assets 3.9% 98.6%
Interest coverage – –
Current ratio 0.9x 34.7x
Quick ratio 0.5x 33.2x
Cash ratio 0.0x 31.3x
Altman Z-score 4.65 1,908

Shareholder Returns

7 metrics
MetricCORGIPL
Dividend yield 0.7% –
Net buyback yield 1.6% -3.2%
Shareholder yield 2.3% -3.2%
Payout ratio (earnings) 17.7% –
Payout ratio (FCF) 11.5% –
Dividend growth (1Y) 8.7% –
Dividend CAGR (3Y) 5.7% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCORGIPL
Forward P/E 19.0xFY2026 –
EPS, next fiscal year $17.08FY2026 –
EPS growth, next FY +6.7%FY2026 –
EPS growth, the year after +11.8% –
Revenue, next fiscal year $328.56BFY2026 –
Revenue growth, next FY +2.2%FY2026 –
Revenue growth, the year after -0.3% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCORGIPL
Held by institutions 94.7% –
Institutions holding 1,343 –
Change in shares held, QoQ +15.7% –
Institutions buying 542 –
Institutions selling 610 –
Buyers to sellers 0.89 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CORGIPL
COR 1.00 0.00
GIPL 0.00 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, COR and GIPL?

Cencora (COR) is the largest by market capitalisation: Cencora (COR) $63.27B, Global Innovative Platforms (GIPL) $24.88M.

Which company is more profitable?

Cencora (COR) has the highest net margin (Cencora (COR) 0.8%, Global Innovative Platforms (GIPL) -361.7%).

Which stock has performed better?

Over the past year Cencora (COR) returned the most: Cencora (COR) -3.3%, Global Innovative Platforms (GIPL) -37.5%. Over five years, Cencora (COR) compounded fastest (Cencora (COR) +21.6%/yr, Global Innovative Platforms (GIPL) -36.9%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Cencora (COR) 0.01%. Global Innovative Platforms (GIPL) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Cencora (COR) has been the steadiest (Cencora (COR) 32.7%, Global Innovative Platforms (GIPL) 270.9%). Volatility measures how widely the price swings, not the risk of the business.

Do COR and GIPL move together?

Their daily returns over the past year have a correlation of -0.00, a negative relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, COR and GIPL?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cencora (COR) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.